CSIMarket
 


Bionik Laboratories Corp   (BNKL)
Other Ticker:  
 
 

BNKL's Net Cash Flow Growth by Quarter and Year

Bionik Laboratories 's Net Cash Flow results by quarter and year




BNKL Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter March -0.26 -2.78 -0.45 0.00
III Quarter December 0.29 4.23 -1.05 -0.08
II Quarter September -0.93 -0.07 0.13 0.08
I Quarter June -0.66 -0.29 1.82 0.07
FY   -1.56 1.09 0.45 0.07



BNKL Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Bionik Laboratories Corp in the fourth quarter 2023 recorded net cash outflow of $ -0.26 millions.

According to the results reported in the fourth quarter 2023, Bionik Laboratories Corp achieved the best Net Cash Flow growth in Medical Equipment & Supplies industry. While Bionik Laboratories Corp ' s Net Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2023.




BNKL Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter March - - - -
III Quarter December -93.14 % - - -
II Quarter September - - 62.5 % -82.22 %
I Quarter June - - 2500 % -
FY   - 142.22 % 542.86 % -

Financial Statements
Bionik Laboratories 's fourth quarter 2023 Net Cash Flow $ -0.26 millions BNKL's Income Statement
Bionik Laboratories 's fourth quarter 2022 Net Cash Flow $ -2.78 millions Quarterly BNKL's Income Statement
New: More BNKL's historic Net Cash Flow Growth >>


BNKL Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - -92.86 % 14.29 %
I Quarter June - - - 0 %
FY (Year on Year)   - 142.22 % 542.86 % -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Bionik Laboratories 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BNKL's IV. Quarter Q/Q Net Cash Flow Comment
Current results of -0.26 millions by Bionik Laboratories Corp look even worse considering the net cash outflow 0.29 millions in the third quarter.

Within Medical Equipment & Supplies industry Bionik Laboratories Corp achieved highest sequential Net Cash Flow growth. While Bionik Laboratories 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BNKL's IV. Quarter Q/Q Net Cash Flow Comment
Recent results of -0.26 millions by Bionik Laboratories Corp appear even less good if you take a look at 0.29 millions net cash outflow a quarter before.

Within Medical Equipment & Supplies industry Bionik Laboratories Corp achieved highest sequential Net Cash Flow growth. While Bionik Laboratories 's Net Cash Flow growth quarter on quarter, overall rank is .


Bionik Laboratories 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ -1.56 $ -4.09 $ -0.14 $ 0.72 $ 1.10
Y / Y Net Cash Flow Growth (TTM) - - - - 144.07 %
Year on Year Net Cash Flow Growth Overall Ranking # 206 # 115 # 0 # 0 # 226
Seqeuential Net Cash Flow Change (TTM) - - - -34.25 % -68 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 457 # 301 # 0 # 731 # 499




Cumulative Net Cash Flow growth Comment
Bionik Laboratories Corp realized trailing twelve months net cash outflow of $ -2 millions, in the Mar 31 2023, compare to Net Cash Flow of $ 1 millions a year ago.

Within the Healthcare sector 29 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 115 to 206.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
144.07 %
-106.03 %
-242.74 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 10
Healthcare Sector # 30
Overall # 206

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
144.07 %
-106.03 %
-242.74 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 76
S&P 500 # 457
Cumulative Net Cash Flow growth Comment
Bionik Laboratories Corp realized trailing twelve months net cash outflow of $ -2 millions, in the Mar 31 2023, compare to Net Cash Flow of $ 1 millions a year ago.

Within the Healthcare sector 29 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 115 to 206.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
144.07 %
-106.03 %
-242.74 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 10
Healthcare Sector # 30
Overall # 206

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
144.07 %
-106.03 %
-242.74 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 76
S&P 500 # 457




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BNKL's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BNKL's Competitors
Net Cash Flow Growth for Bionik Laboratories 's Suppliers
Net Cash Flow Growth for BNKL's Customers

You may also want to know
BNKL's Annual Growth Rates BNKL's Profitability Ratios BNKL's Asset Turnover Ratio BNKL's Dividend Growth
BNKL's Roe BNKL's Valuation Ratios BNKL's Financial Strength Ratios BNKL's Dividend Payout Ratio
BNKL's Roa BNKL's Inventory Turnover Ratio BNKL's Growth Rates BNKL's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2023
Avadel Pharmaceuticals Plc-7.43%$ -7.427 millions
Verastem inc -9.73%$ -9.731 millions
Airsculpt Technologies Inc -11.42%$ -11.424 millions
International Stem Cell Corporation-11.45%$ -11.454 millions
Solid Biosciences Inc -12.39%$ -12.388 millions
2seventy Bio Inc -12.78%$ -12.778 millions
Amylyx Pharmaceuticals Inc -13.91%$ -13.906 millions
Rapt Therapeutics Inc -18.70%$ -18.699 millions
Inotiv Inc -19.20%$ -19.198 millions
Harvard Apparatus Regenerative Technology Inc -20.03%$ -20.032 millions
Verrica Pharmaceuticals Inc -25.90%$ -25.901 millions
Aileron Therapeutics Inc -32.74%$ -32.736 millions
Edwards Lifesciences Corporation-38.18%$ -38.177 millions
Vapotherm Inc -40.24%$ -40.241 millions
Tenon Medical Inc -40.34%$ -40.341 millions
Amedisys Inc -40.47%$ -40.465 millions
Lipocine Inc -41.76%$ -41.758 millions
Satsuma Pharmaceuticals Inc -43.94%$ -43.936 millions
Earth Science Tech Inc -49.87%$ -49.871 millions
Acer Therapeutics Inc -49.93%$ -49.926 millions
Intelgenx Technologies Corp -50.66%$ -50.658 millions
China Health Industries Holdings Inc -51.25%$ -51.248 millions
H cyte Inc-52.86%$ -52.863 millions
Amphastar Pharmaceuticals Inc -55.66%$ -55.662 millions
Infusystem Holdings Inc-58.45%$ -58.447 millions
Siga Technologies Inc-66.30%$ -66.301 millions
Bolt Biotherapeutics Inc -66.39%$ -66.390 millions
Alector Inc -67.14%$ -67.137 millions
Revance Therapeutics Inc -67.18%$ -67.181 millions
Altair International Corp -71.61%$ -71.610 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com